neurontin price

CASL is a multidisciplinary group of scientists and healthcare providers whose expertise focuses on the liver, and provides national leadership in all aspects of research, education and patient care as they pertain to the liver.

Events

Download Final Program

SPEAKER PRESENTATIONS ARE AVAILABLE BY CLICKING THE SESSION TITLES

February 11, 2014

8:00 am Introduction
Kelly Burak, Calgary

Epidemiology & Surveillance

8:10 am HCC In Canada
Morris Sherman, Toronto
8:30 am Surveillance: Evidence and Populations
Jordan Feld, Toronto
8:50 am Surveillance: Tests, Interval, Uptake
Amit Singal, Dallas
9:10 am Panel Discussion and Consensus Statements

Diagnosis

9:30 am Very Early Stage HCC
Morris Sherman, Toronto
9:50 am CT, MRI, LI-RADS
An Tang, Montreal
10:10 am Coffee Break
10:30 am CEUS in the Diagnosis & Management
Stephanie Wilson, Calgary
10:50 am Primovist MRI
Tae Kim, Toronto
11:10 am Panel Discussion and Consensus Statements

Staging and Prognosis

11:30 am BCLC System
Jordi Bruix, Barcelona
11:50 am Predicting Recurrence
Peter Ghali, Montreal
12:10 pm Panel Discussion and Consensus Statements
12:30 pm Lunch

Current Therapies

1:30 pm RFA/PEI
John Kachura, Toronto, ON
1:50 pm Surgery
Sean Cleary, Toronto
2:10 pm Transplantation
Norm Kneteman, Edmonton
2:30 pm Panel Discussion and Consensus Statements
2:50 pm Coffee Break
3:10 pm TACE
Kelly Burak, Calgary
3:30 pm Sorafenib
Andrew Zhu, Boston
3:50 pm Panel Discussion and Consensus Statements

Other Therapies and Future Directions

4:10 pm TARE
Aldo Montano-Loza, Edmonton
4:30 pm SBRT
Laura Dawson, Toronto
4:50 pm New Drugs for HCC
Andrew Zhu, Boston
5:10 pm Panel Discussion and Consensus Statements
5:30 pm Wrap Up and Closing Comments
Morris Sherman, Toronto
5:35 pm Adjourn

 

  • Home
  • About CASL
  • Funding / Awards
  • Events
  • Interest Groups
  • Publications
  • Guidelines
  • Members
  • Links
  • Contact Us

  •   © Copyright 2015 Canadian Association for the Study of the Liver